WIPO Re:Search: Catalyzing collaborations to accelerate product development for diseases of poverty

Chemical Reviews

Volumn 114, Issue 22, 2014, Pages 11272-11279

  Ramamoorthi, Roopa ^a   Graef, Katy M ^a   Krattiger, Anatole ^b   Dent, Jennifer C ^a  

^a BIO Ventures for Global Health   (United States)

^b WORLD INTELLECTUAL PROPERTY ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; PRODUCT DEVELOPMENT;

CELL WALL SYNTHESIS; GLAXO SMITHKLINE; MOLECULAR MECHANISM; NEGLECTED DISEASE; NEW DELHI , INDIA; PHARMACEUTICAL COMPANY; PRIVATE INDUSTRIES; WORLD INTELLECTUAL PROPERTY ORGANIZATIONS;

DISEASES;

ANTIMALARIAL AGENT; PROTEIN KINASE INHIBITOR; TUBERCULOSTATIC AGENT;

COOPERATION; DRUG DESIGN; HUMAN; POVERTY;

ANTIMALARIALS; ANTITUBERCULAR AGENTS; COOPERATIVE BEHAVIOR; DRUG DESIGN; HUMANS; POVERTY; PROTEIN KINASE INHIBITORS;

EID: 84913580920     PISSN: 00092665     EISSN: 15206890     Source Type: Journal    
DOI: 10.1021/cr5000656     Document Type: Review

References (57)

1. Institute for Health Metrics and Evaluation. Global Burden of Disease Compare; Seattle, 2013.
2. Bethony, J. M.; Cole, R. N.; Guo, X.; Kamhawi, S.; Lightowlers, M. W.; Loukas, A.; Petri, W.; Reed, S.; Valenzuela, J. G.; Hotez, P. J. Immunol. Rev. 2011, 239, 237.
3. Hotez, P. Vaccine 2011, 29 (Suppl 4), D104.
4. MSD is known as Merck in the U.S. and Canada.
5. Daniel, T. M. Respir. Med. 2006, 100, 1862.
6. Baddeley, A.; Dean, A.; Dias, H. M.; Falzon, D.; Floyd, K.; Garcia, I.; Glaziou, P.; Hiatt, T.; Law, I.; Lienhardt, C.; Nguyen, L.; Sismanidis, C.; Timimi, H.; van Gemert, W.; Zignol, M. Global Tuberculosis Report 2013; World Health Organization: Geneva, 2013.
7. Andrews, K.; Aregawi, M.; Cibulskis, R.; Fergus, C.; Lynch, M.; Newman, R.; Szilagyi, Z.; Williams, R. World Malaria Report 2013; World Health Organization: Geneva, 2013.
8. Bhatt, S.; Gething, P. W.; Brady, O. J.; Messina, J. P.; Farlow, A. W.; Moyes, C. L.; Drake, J. M.; Brownstein, J. S.; Hoen, A. G.; Sankoh, O.; Myers, M. F.; George, D. B.; Jaenisch, T.; Wint, G. R.; Simmons, C. P.; Scott, T. W.; Farrar, J. J.; Hay, S. I. Nature 2013, 496, 504.
9. Koul, A.; Arnoult, E.; Lounis, N.; Guillemont, J.; Andries, K. Nature 2011, 469, 483.
10. Baddeley, A.; Dias, H. M.; Falzon, D.; Fitzpatrick, C.; Floyd, K.; Gilpin, C.; Glaziou, P.; Hiatt, T.; Pantoja, A.; Sculier, D.; Sismanidis, C.; Timimi, H.; Uplekar, M.; van Gemert, W. Global Tuberculosis Control 2011; World Health Organization: Geneva, 2011.
11. Centers for Disease Control and Prevention. TB Elimination Multidrug-Resistant Tuberculosis (MDR TB); Atlanta, 2012.
12. World Health Organization. Multidrug-Resistant Tuberculosis (MDR-TB) 2013 Update; Geneva, 2013.
13. Klopper, M.; Warren, R. M.; Hayes, C.; Gey van Pittius, N. C.; Streicher, E. M.; Muller, B.; Sirgel, F. A.; Chabula-Nxiweni, M.; Hoosain, E.; Coetzee, G.; David van Helden, P.; Victor, T. C.; Trollip, A. P. Emerging Infect. Dis. 2013, 19, 449.
14. Koul, A.; Arnoult, E.; Lounis, N.; Guillemont, J.; Andries, K. Nature 2011, 469, 483.
15. Pawlowski, A.; Jansson, M.; Skold, M.; Rottenberg, M. E.; Kallenius, G. PLoS Pathog. 2012, 8, e1002464.
16. Getahun, H.; Gunneberg, C.; Granich, R.; Nunn, P. Clin. Infect. Dis. 2010, 50 (Suppl 3), S201.
17. Camp, D.; Newman, S.; Pham, N. B.; Quinn, R. J. Comb. Chem. High Throughput Screening 2014, 17, 201.
18. Wada, T.; Penninger, J. M. Oncogene 2004, 23, 2838.
19. Henneke, G.; Koundrioukoff, S.; Hubscher, U. EMBO Rep. 2003, 4, 252.
20. Trovesi, C.; Manfrini, N.; Falcettoni, M.; Longhese, M. P. J. Mol. Biol. 2013, 425, 4756.
21. Gehart, H.; Kumpf, S.; Ittner, A.; Ricci, R. EMBO Rep. 2010, 11, 834.
22. Arthur, J. S.; Ley, S. C. Nat. Rev. Immunol. 2013, 13, 679.
23. Piper, R.; Bryant, N. Trafficking Inside Cells: Pathways, Mechanisms and Regulation; Landes Bioscience and Springer Science + Business Media: Austin, TX, 2009, 363.
24. Kondapalli, L.; Soltani, K.; Lacouture, M. E. J. Am. Acad. Dermatol. 2005, 53, 291.
25. Pray, L. A. Nat. Educ. 2008, 1, 37.
26. Druker, B. J.; Talpaz, M.; Resta, D. J.; Peng, B.; Buchdunger, E.; Ford, J. M.; Lydon, N. B.; Kantarjian, H.; Capdeville, R.; Ohno-Jones, S.; Sawyers, C. L. N. Engl. J. Med. 2001, 344, 1031.
27. Taylor, S. S.; Radzio-Andzelm, E. Structure 1994, 2, 345.
28. Hanks, S. K.; Hunter, T. FASEB J. 1995, 9, 576.
29. Knapp, S.; Arruda, P.; Blagg, J.; Burley, S.; Drewry, D. H.; Edwards, A.; Fabbro, D.; Gillespie, P.; Gray, N. S.; Kuster, B.; Lackey, K. E.; Mazzafera, P.; Tomkinson, N. C.; Willson, T. M.; Workman, P.; Zuercher, W. J. Nat. Chem. Biol. 2013, 9, 3.
30. Favrot, L.; Ronning, D. R. Expert Rev. Anti-Infect. Ther. 2012, 10, 1023.
31. World Health Organization. Malaria Fact Sheet No. 94; Geneva, 2014.
32. Kim, Y.; Schneider, K. A. Nat. Educ. Knowl. 2013, 4, 6.
33. Cowman, A. F.; Berry, D.; Baum, J. J. Cell Biol. 2012, 198, 961.
34. Sharma, P.; Chitnis, C. E. Curr. Opin. Microbiol. 2013, 16, 432.
35. Kumar, A.; Vaid, A.; Syin, C.; Sharma, P. J. Biol. Chem. 2004, 279, 24255.
36. Vaid, A.; Sharma, P. J. Biol. Chem. 2006, 281, 27126.
37. Vaid, A.; Thomas, D. C.; Sharma, P. J. Biol. Chem. 2008, 283, 5589.
38. Ahmed, A.; Gaadhe, K.; Sharma, G. P.; Kumar, N.; Neculai, M.; Hui, R.; Mohanty, D.; Sharma, P. FASEB J. 2012, 26, 3212.
39. Ranjan, R.; Ahmed, A.; Gourinath, S.; Sharma, P. J. Biol. Chem. 2009, 284, 15267.
40. Solyakov, L.; Halbert, J.; Alam, M. M.; Semblat, J. P.; Dorin-Semblat, D.; Reininger, L.; Bottrill, A. R.; Mistry, S.; Abdi, A.; Fennell, C.; Holland, Z.; Demarta, C.; Bouza, Y.; Sicard, A.; Nivez, M. P.; Eschenlauer, S.; Lama, T.; Thomas, D. C.; Sharma, P.; Agarwal, S.; Kern, S.; Pradel, G.; Graciotti, M.; Tobin, A. B.; Doerig, C. Nat. Commun. 2011, 2, 565.
41. Dickson, M.; Gagnon, J. P. Discovery Med. 2004, 4, 172.
42. Levine, D. S. New Estimate of Drug Development Costs Pegs Total at $1.5 Billion. The Burrill Report, Dec 7, 2012.
43. DiMasi, J. A.; Feldman, L.; Seckler, A.; Wilson, A. Clin. Pharmacol. Ther. 2010, 87, 272.
44. World Health Organization. Diarrhoeal Disease Fact Sheet No. 330; Geneva, 2013.
45. Keusch, G. T.; Fontaine, O.; Bhargava, A.; Boschi-Pinto, C.; Bhutta, Z. A.; Gotuzzo, E.; Rivera, J.; Chow, J.; Shahid-Salles, S.; Laxminarayan, R. Disease Control Priorities in Developing Countries, 2nd Ed.; World Bank: Washington, DC, 2006; p 371.
46. Guerrant, R. L.; Oria, R. B.; Moore, S. R.; Oria, M. O.; Lima, A. A. Nutr. Rev. 2008, 66, 487.
47. Hirschhorn, N.; Kinzie, J. L.; Sachar, D. B.; Northrup, R. S.; Taylor, J. O.; Ahmad, S. Z.; Phillips, R. A. N. Engl. J. Med. 1968, 279, 176.
48. Bajait, C.; Thawani, V. Indian J. Pharmacol. 2011, 43, 232.
49. Khan, W. U.; Sellen, D. W. In e-Library of Evidence for Nutrition Actions (eLENA); World Health Organization: Geneva, 2011.
50. Hodges, K.; Gill, R. Gut Microbes 2010, 1, 4.
51. Rufo, P. A.; Merlin, D.; Riegler, M.; Ferguson-Maltzman, M. H.; Dickinson, B. L.; Brugnara, C.; Alper, S. L.; Lencer, W. I. J. Clin. Invest. 1997, 100, 3111.
52. Stocker, J. W.; De Franceschi, L.; McNaughton-Smith, G. A.; Corrocher, R.; Beuzard, Y.; Brugnara, C. Blood 2003, 101, 2412.
53. Wulff, H.; Castle, N. A. Expert Rev. Clin. Pharmacol. 2010, 3, 385.
54. Duffy, S. M.; Cruse, G.; Lawley, W. J.; Bradding, P. FASEB J. 2005, 19, 1006.
55. Drewry, D.; Zuercher, B. 2nd RSC Symposium on Chemical Biology for Drug Discovery, Macclesfield, U. K., March 20-21, 2012.
56. Drewry, D. H.; Willson, T. M.; Zuercher, W. J. Curr. Top. Med. Chem. 2014, 14, 340.
57. Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S. Science 2002, 298, 1912.